First Trust Advisors
BMRN icon

First Trust Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$40.6M Buy
738,482
+69,001
+10% +$3.79M 0.03% 647
2025
Q1
$47.3M Buy
669,481
+39,496
+6% +$2.79M 0.04% 556
2024
Q4
$41.4M Buy
629,985
+162,687
+35% +$10.7M 0.04% 609
2024
Q3
$32.8M Buy
467,298
+63,274
+16% +$4.45M 0.03% 633
2024
Q2
$33.3M Sell
404,024
-72,507
-15% -$5.97M 0.03% 617
2024
Q1
$41.6M Sell
476,531
-103,400
-18% -$9.03M 0.04% 536
2023
Q4
$55.9M Buy
579,931
+56,532
+11% +$5.45M 0.06% 406
2023
Q3
$46.3M Buy
523,399
+17,438
+3% +$1.54M 0.05% 439
2023
Q2
$43.9M Buy
505,961
+12,099
+2% +$1.05M 0.05% 482
2023
Q1
$48M Sell
493,862
-8,262
-2% -$803K 0.06% 457
2022
Q4
$52M Sell
502,124
-53,169
-10% -$5.5M 0.06% 442
2022
Q3
$47.1M Sell
555,293
-43,066
-7% -$3.65M 0.06% 446
2022
Q2
$49.6M Sell
598,359
-5,289
-0.9% -$438K 0.06% 447
2022
Q1
$46.5M Sell
603,648
-521,126
-46% -$40.2M 0.05% 519
2021
Q4
$99.4M Buy
1,124,774
+41,888
+4% +$3.7M 0.1% 253
2021
Q3
$83.7M Sell
1,082,886
-132,988
-11% -$10.3M 0.09% 283
2021
Q2
$101M Buy
1,215,874
+86,213
+8% +$7.19M 0.11% 233
2021
Q1
$85.3M Buy
1,129,661
+299,286
+36% +$22.6M 0.1% 248
2020
Q4
$72.8M Sell
830,375
-184,481
-18% -$16.2M 0.1% 274
2020
Q3
$77.2M Sell
1,014,856
-129,950
-11% -$9.89M 0.12% 204
2020
Q2
$141M Buy
1,144,806
+387,808
+51% +$47.8M 0.24% 95
2020
Q1
$64M Sell
756,998
-109,093
-13% -$9.22M 0.14% 189
2019
Q4
$73.2M Buy
866,091
+8,866
+1% +$750K 0.13% 211
2019
Q3
$57.8M Sell
857,225
-391,836
-31% -$26.4M 0.11% 249
2019
Q2
$107M Sell
1,249,061
-12,847
-1% -$1.1M 0.2% 113
2019
Q1
$112M Buy
1,261,908
+174,499
+16% +$15.5M 0.22% 99
2018
Q4
$92.6M Sell
1,087,409
-140,091
-11% -$11.9M 0.22% 86
2018
Q3
$119M Buy
1,227,500
+523,649
+74% +$50.8M 0.22% 86
2018
Q2
$66.3M Buy
703,851
+87,468
+14% +$8.24M 0.14% 146
2018
Q1
$50M Buy
616,383
+30,545
+5% +$2.48M 0.11% 193
2017
Q4
$52.2M Buy
585,838
+10,900
+2% +$972K 0.12% 180
2017
Q3
$53.5M Buy
574,938
+144,651
+34% +$13.5M 0.14% 157
2017
Q2
$39.1M Buy
430,287
+42,730
+11% +$3.88M 0.1% 224
2017
Q1
$34M Sell
387,557
-86,505
-18% -$7.59M 0.09% 256
2016
Q4
$39.3M Buy
474,062
+122,469
+35% +$10.1M 0.12% 190
2016
Q3
$32.5M Sell
351,593
-47,223
-12% -$4.37M 0.1% 243
2016
Q2
$31M Sell
398,816
-45,955
-10% -$3.58M 0.1% 247
2016
Q1
$36.7M Sell
444,771
-727,546
-62% -$60M 0.12% 202
2015
Q4
$123M Sell
1,172,317
-295,520
-20% -$31M 0.32% 55
2015
Q3
$155M Sell
1,467,837
-280,208
-16% -$29.5M 0.45% 18
2015
Q2
$239M Sell
1,748,045
-24,051
-1% -$3.29M 0.62% 9
2015
Q1
$221M Buy
1,772,096
+595,536
+51% +$74.2M 0.65% 10
2014
Q4
$106M Buy
1,176,560
+21,164
+2% +$1.91M 0.36% 40
2014
Q3
$83.4M Buy
1,155,396
+208,123
+22% +$15M 0.33% 38
2014
Q2
$58.9M Buy
947,273
+35,990
+4% +$2.24M 0.24% 62
2014
Q1
$62.2M Sell
911,283
-58,014
-6% -$3.96M 0.27% 45
2013
Q4
$68.2M Buy
969,297
+265,400
+38% +$18.7M 0.33% 34
2013
Q3
$50.8M Sell
703,897
-14,308
-2% -$1.03M 0.28% 52
2013
Q2
$40M Buy
+718,205
New +$40M 0.26% 63